Placebo group (n = 35) | Dexamethasone group (n = 35) | |
---|---|---|
Age (years)a | 49.89 ± 10.58 | 50.11 ± 12.37 |
Weight (kg)a | 67.94 ± 9.91 | 69.52 ± 13.63 |
Height (cm)a | 158.14 ± 6.33 | 157.31 ± 6.57 |
Body mass indexa | 27.20 ± 4.29 | 28.20 ± 6.38 |
Normal weight 20-25 (%) | 11 (31.4%) | 12 (34.3%) |
Overweight 25.1-29.9 (%) | 15 (42.9%) | 14 (40%) |
Obesity grade I 30-34.9 (%) | 7 (20%) | 5 (14.3%) |
Obesity grade II 35-39.9 (%) | 2 (5.7%) | 2 (5.7%) |
Obesity grade III >40 (%) | 0 | 2 (5.7%) |
Smoking (%) | 2 (5.7%) | 4 (11.4%) |
Neoadjuvant chemotherapy (%) | 13 (37.1%) | 15 (42.8%) |
Surgical procedure | ||
Radical mastectomy + axillary dissection (%) | 32 (91.4%) | 34 (97.1%) |
Quadrantectomy + axillary dissection (%) | 3 (8.6%) | 1 (2.9%) |
Surgery time (min)a | 119.42 ± 26.97 | 120.54 ± 30.34 |
Length of anesthesia (min)a | 140.71 ± 26.76 | 139.60 ± 34.56 |
Bleeding (ml)a | 165.85 ± 61.10 | 156.85 ± 60.11 |